Quote:

---

Until now, Adia Med's operations have depended solely on out-of-pocket payments from patients. However, the shift to accepting private insurance promises to transform patient care by:

Increasing Affordability: By lowering the cost barrier, AHSCT and injectable stem cell treatments will be within reach for a broader demographic, significantly reducing the financial strain on individuals seeking these advanced medical solutions.

Enhancing Accessibility: More patients will have the opportunity to benefit from these therapies without the immediate financial burden, fostering health equity.

Strengthening Partnerships: Developing robust relationships with insurance providers to integrate Adia Med's treatments into various health coverage plans.

---